Live news related to INTEGRAGEN stock (FR0010908723): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on INTEGRAGEN mainly cover M&A activity. The stock trades at €0,08 on Euronext Paris at the last update. This page lists the articles published on INTEGRAGEN stock to track the share price, company announcements and any item likely to influence market perception.
On October 29, 2026, IntegraGen published its estimated, unaudited results for the first half of 2026, the first prepared since the opening of its jud…
In a press release published on October 26, 2026, IntegraGen announced that it is continuing its operations as part of its judicial reorganization pro…
Approved by the Évry commercial court on October 9, 2026, ABL Texcell Diagnostics' offer brings IntegraGen's assets and operations, placed under judic…
The Commercial Court of Évry examined on October 5, 2026 the acquisition proposals for IntegraGen, a specialist in cancer genomics and rare genetic di…
